McKesson Corp. diskutieren
McKesson Corp.
WKN: 893953 / Symbol: MCK / Name: McKesson / Aktie / Lebensmittel- & Medikamentenhandel / Large Cap /
693,60 €
-0,49 %
McKesson Co. (NYSE: MCK) had its price target raised by analysts at Evercore ISI from $650.00 to $675.00. They now have an "outperform" rating on the stock.
Ratings data for MCK provided by MarketBeat
McKesson Co. (NYSE: MCK) had its price target raised by analysts at Morgan Stanley from $642.00 to $745.00. They now have an "overweight" rating on the stock.
Ratings data for MCK provided by MarketBeat
McKesson Co. (NYSE: MCK) had its price target raised by analysts at Bank of America Co. from $665.00 to $755.00. They now have a "buy" rating on the stock.
Ratings data for MCK provided by MarketBeat
McKesson Co. (NYSE: MCK) had its price target raised by analysts at UBS Group AG from $708.00 to $805.00. They now have a "buy" rating on the stock.
Ratings data for MCK provided by MarketBeat
Buy McKesson Corp.
.jpeg?locale=de "Fady")
McKesson Co. (NYSE: MCK) had its price target raised by analysts at Bank of America Co. from $755.00 to $800.00. They now have a "buy" rating on the stock.
Ratings data for MCK provided by MarketBeat
McKesson Co. (NYSE: MCK) had its price target raised by analysts at Morgan Stanley from $745.00 to $770.00. They now have an "overweight" rating on the stock.
Ratings data for MCK provided by MarketBeat
McKesson Corporation (NYSE: MCK) had its price target raised by analysts at Evercore ISI from $760.00 to $800.00. They now have an "outperform" rating on the stock.
Ratings data for MCK provided by MarketBeat
McKesson Corporation (NYSE: MCK) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Ratings data for MCK provided by MarketBeat
McKesson Corporation (NYSE: MCK) had its price target raised by analysts at Morgan Stanley from $770.00 to $810.00. They now have an "overweight" rating on the stock.
Ratings data for MCK provided by MarketBeat
McKesson Corporation (NYSE: MCK) had its "buy" rating re-affirmed by analysts at Cowen Inc.
Ratings data for MCK provided by MarketBeat
McKesson (NYSE:MCK) had its price target raised by analysts at UBS Group AG from $820.00 to $860.00. They now have a "buy" rating on the stock.
Ratings data for MCK provided by MarketBeat
McKesson (NYSE:MCK) had its price target raised by analysts at Leerink Partners from $785.00 to $850.00. They now have an "outperform" rating on the stock.
Ratings data for MCK provided by MarketBeat
McKesson (NYSE:MCK) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $775.00 to $856.00. They now have a "buy" rating on the stock.
Ratings data for MCK provided by MarketBeat
McKesson (NYSE:MCK) had its price target raised by analysts at Bank of America Corporation from $800.00 to $850.00. They now have a "buy" rating on the stock.
Ratings data for MCK provided by MarketBeat
McKesson (NYSE:MCK) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for MCK provided by MarketBeat
McKesson (NYSE:MCK) had its price target raised by analysts at Morgan Stanley from $810.00 to $857.00. They now have an "overweight" rating on the stock.
Ratings data for MCK provided by MarketBeat
McKesson (NYSE:MCK) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for MCK provided by MarketBeat
McKesson (NYSE:MCK) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Ratings data for MCK provided by MarketBeat
McKesson (NYSE:MCK) had its price target raised by analysts at TD Cowen from $830.00 to $864.00. They now have a "buy" rating on the stock.
Ratings data for MCK provided by MarketBeat
Neueste Beiträge
Barclays_PLC in Vertex Pharmaceuticals Inc. diskutieren